Biotech article - March 19, 2025
Scaling the next generation of T-cell therapy
Understanding the science is one thing, but being able to manufacture T-cell therapies at scale is a different matter. TCR-T cell therapies offer a path forward at a fraction of the cost and time of manufacturing a living cell as a product.
CMO - January 17, 2017
Surviving as a CMO
What are the key factors for survival as a CMO today? We have spoken to some Nordic CMOs to get an insight into the current possibilities and challenges. The pharmaceutical sector is undergoing some dramatic changes, with pipeline challenges, pricing pressures and emerging global markets reshaping the way that companies operate. The CMO marketplace has […]
Acquisition - January 9, 2017
PolyPeptide completes acquisition of Lonza’s peptides business
The PolyPeptide Group has announced that the acquisition of the peptides business and operations of Lonza in Braine-l’Alleud, Belgium has been completed. The Braine facility, with approximately 280 employees, was the center for peptide chemical development and manufacturing within Lonza. The acquisition will enhance PolyPeptide’s manufacturing capacity and capabilities and will enable seamless support for its […]
CMO - December 12, 2012
CMOs on the rise
How do you establish yourself as a successful CMO? What does the future look like for CMOs over the coming years? Nordic Life Science Review takes a look at some of the developments and trends among contract manufacturing organizations in the Nordic countries. The life science industry has been through a few difficult years and […]
